BCL2L1 and infection: Further investigation revealed that BCL-xL levels increase while Bax levels decrease in response to infection and the TRP120 Wnt SLiM, and this result is abrogated by treatment with Verteporfin, a YAP inhibitor (Liu-Chittenden et al., 2012; Byerly et al., 2023).